Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 4
1974 1
1975 1
1976 2
1977 10
1978 15
1979 6
1980 10
1981 10
1982 21
1983 13
1984 13
1985 21
1986 25
1987 20
1988 31
1989 32
1990 42
1991 35
1992 41
1993 48
1994 37
1995 50
1996 53
1997 46
1998 55
1999 56
2000 54
2001 52
2002 56
2003 72
2004 82
2005 84
2006 104
2007 108
2008 103
2009 100
2010 84
2011 108
2012 101
2013 98
2014 108
2015 88
2016 92
2017 103
2018 110
2019 98
2020 82
2021 89
2022 106
2023 102
2024 102
2025 17

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,725 results

Results by year

Filters applied: . Clear all
Page 1
Segmental and Focal Glomerulosclerosis Secondary to MELAS Syndrome and Long-Term Outcomes After Kidney Transplant: Case Report and Literature Review.
Vinicius de Sousa M, Mariani G, Ribeiro Alves MAVF, Mazzali M. Vinicius de Sousa M, et al. Exp Clin Transplant. 2025 Feb;23(2):146-150. doi: 10.6002/ect.2025.0006. Exp Clin Transplant. 2025. PMID: 40094257 Free article. Review.
Tubular cells and podocytes can be affected by these diseases, resulting in diverse clinical and laboratory manifestations. We reported a case of a 31-year-old female patient with bilateral sensorineural deafness diagnosed with the m.3243AG sequence variant in adulthood. A …
Tubular cells and podocytes can be affected by these diseases, resulting in diverse clinical and laboratory manifestations. We report …
Clinicopathological characteristics and outcomes of patients with unexplained renal impairment: A single center study.
Ellisy RA, Tony EA, Ismail W, Radi R, Seddik MI, Abdel Aziz EM. Ellisy RA, et al. Nefrologia (Engl Ed). 2025 Mar;45(3):249-258. doi: 10.1016/j.nefroe.2025.02.012. Nefrologia (Engl Ed). 2025. PMID: 40082054 Free article.
Descriptive statistics were used to summarize data on patient demographics, histopathological patterns, and outcomes after three months. CLINICAL TRIAL REGISTRATION NUMBER: NCT03586531. RESULTS: Overall, 210 native renal biopsies were included in the analysis. ...
Descriptive statistics were used to summarize data on patient demographics, histopathological patterns, and outcomes after three months. …
Long-term efficacy of Rituximab in steroid dependent and frequent relapsing adult nephrotic syndrome.
Feder O, Amsterdam D, Ershed M, Grupper A, Schwartz D, Kliuk-Ben Bassat O. Feder O, et al. BMC Nephrol. 2025 Mar 6;26(1):126. doi: 10.1186/s12882-025-04035-0. BMC Nephrol. 2025. PMID: 40050772 Free PMC article.
BACKGROUND: Corticosteroids are highly efficient for treatment of minimal change disease (MCD), however a substantial number of patients become steroid dependent (SD) or frequent relapsing (FR). Response rate is lower in primary Focal Segmental Glomerulosclerosis …
BACKGROUND: Corticosteroids are highly efficient for treatment of minimal change disease (MCD), however a substantial number of patients bec …
Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application.
Moedt E, Wasehuus VS, Heerspink HJL. Moedt E, et al. Nephrol Dial Transplant. 2025 Feb 5;40(Supplement_1):i37-i46. doi: 10.1093/ndt/gfae214. Nephrol Dial Transplant. 2025. PMID: 39907539 Free PMC article. Review.
These include diabetic kidney disease, immunoglobulin A nephropathy, focal segmental glomerulosclerosis and Alport syndrome. Accordingly, selective ETA endothelin receptor antagonists (ERA) may prove a viable therapeutic option in these diseases. However, …
These include diabetic kidney disease, immunoglobulin A nephropathy, focal segmental glomerulosclerosis and Alport synd …
[Short-term efficacy of rituximab in children with calcineurin inhibitor resistant steroid resistant nephrotic syndrome].
Yu SS, Liu JL, Liu JJ, Fang XY, Chen J, Miao QF, Tang XS, Zhang ZQ, Wang CY, Dai RF, Han XL, Zhai YH, Xu H, Shen Q. Yu SS, et al. Zhonghua Er Ke Za Zhi. 2025 Feb 2;63(2):185-189. doi: 10.3760/cma.j.cn112140-20240714-00482. Zhonghua Er Ke Za Zhi. 2025. PMID: 39844495 Chinese.
The age of disease onset was 4.0 (2.9, 6.8) years and the age of RTX treatment was 9.8 (5.9, 13.6) years. There were 8 cases of focal segmental glomerulosclerosis, 3 cases of minimal change disease and 2 cases of mesangial proliferative glomerulonephritis. .. …
The age of disease onset was 4.0 (2.9, 6.8) years and the age of RTX treatment was 9.8 (5.9, 13.6) years. There were 8 cases of focal …
Etiological spectrum and short-term outcomes of acute kidney injury in hospitalised patients of uncertain aetiology who underwent percutaneous renal biopsy.
Huzaifa QM, Elahi T, Jahangir S, Khan K, Memon I. Huzaifa QM, et al. J Pak Med Assoc. 2025 Jan;75(1):25-30. doi: 10.47391/JPMA.23005. J Pak Med Assoc. 2025. PMID: 39828822 Free article.
OBJECTIVES: To analyse the aetiological spectrum, clinical presentation and short-term renal outcomes of patients with acute kidney injury of uncertain aetiology subjected to percutaneous renal biopsy. ...The most common primary glomerular diseases were focal seg …
OBJECTIVES: To analyse the aetiological spectrum, clinical presentation and short-term renal outcomes of patients with acute kidney i …
Traditional, alternative, and emerging therapeutics for focal segmental glomerulosclerosis.
Di Carlo S, Longhitano E, Spinella C, Maressa V, Casuscelli C, Peritore L, Santoro D. Di Carlo S, et al. Expert Opin Pharmacother. 2025 Feb;26(2):179-186. doi: 10.1080/14656566.2024.2446621. Epub 2025 Jan 1. Expert Opin Pharmacother. 2025. PMID: 39743782 Review.
INTRODUCTION: Segmental focal glomerulosclerosis is a histological lesion characterized by podocyte damage. ...Finally, personalized treatment requires stratifying patients based on clinical, genetic, and histological data to improve clinical …
INTRODUCTION: Segmental focal glomerulosclerosis is a histological lesion characterized by podocyte damage. ...Finally, …
Renal survival and treatment of adult patients with Primary Focal Segmental glomerulosclerosis: A historical cohort study of the National Greek Registry.
Marinaki S, Kompotiatis P, Michelakis I, Stangou M, Papagianni A, Koukoulaki M, Zerbala S, Xydakis D, Kaperonis N, Dounousi E, Golfinopoulos S, Stefanidis I, Paikopoulou A, Moustakas G, Stylianou K, Tzanakis I, Papasotiriou M, Goumenos D, Andrikos A, Kriki P, Panagoutsos S, Kiousi E, Grapsa E, Koutroumpas G, Pateinakis P, Papadopoulou D, Liakopoulos V, Bacharaki D, Kouki P, Petras D, Bamichas G, Boletis I. Marinaki S, et al. PLoS One. 2024 Dec 18;19(12):e0315124. doi: 10.1371/journal.pone.0315124. eCollection 2024. PLoS One. 2024. PMID: 39693288 Free PMC article.
BACKGROUND/OBJECTIVE: Primary Focal and Segmental glomerulosclerosis (FSGS) is one of the most common causes of idiopathic nephrotic syndrome. ...CONCLUSION: In primary FSGS, complete and partial remission were associated with improved renal survival. Further …
BACKGROUND/OBJECTIVE: Primary Focal and Segmental glomerulosclerosis (FSGS) is one of the most common causes of idiopat …
Efficacy and safety of nine immunosuppressive agents for primary focal segmental glomerulosclerosis in adults: a pairwise and network meta-analysis.
Zhu Y, Chen B, Xu G. Zhu Y, et al. Ren Fail. 2024 Dec;46(2):2438861. doi: 10.1080/0886022X.2024.2438861. Epub 2024 Dec 11. Ren Fail. 2024. PMID: 39663153 Free PMC article.
BACKGROUND: Immunosuppressants are widely used as the preferred treatment for primary focal segmental glomerulosclerosis (pFSGS). Nevertheless, controversies persist regarding the effectiveness and side effects of different immunosuppressive medications. METH …
BACKGROUND: Immunosuppressants are widely used as the preferred treatment for primary focal segmental glomerulosclerosis …
Unveiling the podocyte-protective effect of sodium-glucose cotransporter-2 inhibitors.
Jiang B, Cheng Z, Wang D, Liu F, Wang J, Fu H, Mao J. Jiang B, et al. Kidney Res Clin Pract. 2025 Jan;44(1):69-78. doi: 10.23876/j.krcp.24.144. Epub 2024 Dec 5. Kidney Res Clin Pract. 2025. PMID: 39639415 Free PMC article.
Furthermore, reductions in lipotoxicity, oxidative stress, and inflammation have been confirmed with SGLT2 inhibitor treatment. Recent clinical studies have also begun to explore the effects of SGLT2 inhibitors on nondiabetic podocytopathies, such as focal segmen …
Furthermore, reductions in lipotoxicity, oxidative stress, and inflammation have been confirmed with SGLT2 inhibitor treatment. Recent cl …
2,725 results